Eli Lilly

Survey: 80% of big pharma companies restructuring to strategically outsource more trials to CROs

Monday, October 31, 2011 08:00 AM

According to a recent survey from William Blair, about 80% of big pharma companies either are in the process of restructuring or have already completed restructuring plans to strategically outsource more of their trials to CROs.

More... »

Lilly selects Prasco to market generics

Friday, October 28, 2011 11:28 AM

Prasco Laboratories has signed a marketing and distribution agreement with Eli Lilly to market the authorized generic version of ZYPREXA (olanzapine) tablets and ZYPREXA ZYDIS (olanzapine) orally disintegrating tablets, in the U.S.

More... »

Quintiles to acquire Advion BioServices

Wednesday, October 26, 2011 12:01 PM

Quintiles has agreed to buy Advion BioServices, a 19-year-old bioanalytical lab that recently penned a strategic partnership with Eli Lilly.

More... »

Pearl IRB expands into compliance and consulting

Monday, October 17, 2011 08:00 AM

Indianapolis-based Pearl IRB is expanding. The commercial institutional review board, launched just last year, is now adding a regulatory and compliance division, as well as a consulting division that will focus on helping life sciences startups.

More... »

Oncobiologics names Canute to board of directors

Wednesday, October 12, 2011 11:31 AM

Oncobiologics has named Scott Canute to its board of directors.

More... »

Drug sponsors join research partnership to accelerate drug discovery

Thursday, September 29, 2011 01:21 PM

In a bid to save both time and money, some of the industry's biggest names are experimenting with new ways to pool early-stage research, effectively taking a leaf out of the "open-source" manual that gave the world Linux software, according to Reuters.

More... »

Lilly steps up efforts to improve minority enrollment in clinical trials

Thursday, September 22, 2011 02:08 PM

Targeted trial sites, information on patient-assistance programs, on-site visits, culturally sensitive patient materials and amended protocol designs can all help to increase minority participation in clinical trials, a US study by Eli Lilly has indicated, according to PharmaTimes.

More... »

Lilly expects original drugs sales to triple in India

Friday, September 16, 2011 11:15 AM

American drug maker Eli Lilly will bet on its original drugs as it aims to triple sales in India over the next five years. Unlike other foreign drug makers, it plans to stay away from acquisition of local firms or branded generics to boost its market share, according to The Economic Times.

More... »

Eli Lilly maximizes presence on social media

Friday, September 16, 2011 10:41 AM

Last week the company launched a new YouTube channel and tomorrow Lilly will make its official corporate debut on Facebook, according to InPharm.

More... »

Lilly allows researchers to submit compounds online

Thursday, September 15, 2011 10:30 AM

Combine an intense ambition to slash the 10 years and $800 million it takes to develop new medicines with the ability to encode promising new compounds so they can be digitally tested without revealing their full traits. Add academic researchers worldwide who'd like to know if they've discovered a valuable new drug, but are wary of handing it over to a big drug maker. The result is Eli Lilly's inspired Open Innovation Drug Discovery program, according to Information Week.

More... »